The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

Patients and clinicians can be reassured that prescription of an ACEi or ARB at the time of COVID-19 diagnosis is not harmful. The benefit of prescription of an ACEi or ARB in reducing hospital stay is a new finding.